Groundbreaking Study Confirms Clinical Decision Impact of HER2DX® Genomic Assay in Early-Stage HER2-Positive Breast Cancer – Business Wire
Comunicato stampa – Responsabilità editoriale di Business Wire REVEAL GENOMICS ® , a pioneering Barcelona-based biotech company dedicated to advancing precision oncology, is proud to announce the publication of a…
